INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2024) I. Quarter |
(Mar 31 2024) IV. Quarter |
(Dec 31 2023) III. Quarter |
(Sep 30 2023) II. Quarter |
(Jun 30 2023) I. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
71.34 |
|
71.93 |
75.68 |
91.79 |
Other Revenue |
-0.21 |
|
-0.75 |
-0.94 |
-0.85 |
Total Revenue |
71.14 |
9.62 |
71.18 |
74.74 |
90.93 |
Cost of Goods and Services Sold |
45.00 |
12.21 |
42.00 |
42.00 |
56.00 |
Gross
Profit |
26.14 |
21.84 |
29.18 |
32.74 |
34.93 |
Selling, Administration, Marketing |
13.30 |
13.12 |
14.24 |
15.72 |
15.84 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
8.31 |
5.33 |
8.76 |
9.15 |
10.91 |
Restructuring Charges |
1.19 |
1.07 |
0.50 |
1.34 |
1.33 |
Other operatinig exp. /-income |
21.07 |
-8.49 |
11.89 |
10.24 |
12.70 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
88.86 |
23.25 |
77.40 |
78.45 |
96.78 |
Operating income/-loss
|
-17.73 |
-13.63 |
-6.22 |
-3.71 |
-5.85 |
Other Deductions / - Income |
Interest expense |
- |
8.65 |
- |
- |
3.20 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
8.65 |
- |
- |
3.20 |
Extinguishment of Debt |
0.70 |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
0.04 |
-4.71 |
1.42 |
-0.91 |
1.00 |
Interest Expense Nonoperating |
3.79 |
- |
3.94 |
- |
- |
Fair Value Adjustment Of Warrants |
-1.67 |
- |
-2.21 |
- |
- |
Total costs & expenses |
91.72 |
27.19 |
80.54 |
77.53 |
100.98 |
Income /-loss before income taxes |
-20.59 |
-17.57 |
-9.36 |
-2.80 |
-10.05 |
Income taxes expenses/-benefit |
0.24 |
-0.97 |
0.51 |
0.53 |
0.53 |
Income after income taxes |
-20.82 |
-16.60 |
-9.87 |
-3.33 |
-10.58 |
Net income/-loss
of other equity |
- |
- |
- |
- |
0.00 |
Income/-loss
from cont. Ops. |
-20.82 |
-16.60 |
-9.87 |
-3.33 |
-10.58 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-20.82 |
-16.60 |
-9.87 |
-3.33 |
-10.58 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-20.82 |
-16.60 |
-9.87 |
-3.33 |
-10.58 |
EBIT |
-20.59 |
-8.92 |
-9.36 |
-2.80 |
-6.85 |
EBITD |
-18.81 |
-8.92 |
-4.52 |
-0.26 |
-4.09 |
EBITDA |
-18.00 |
-8.92 |
-3.09 |
0.46 |
-3.57 |